ESCAPE-NEXT Trial

ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.

For more information about the trial, contact:

University of Calgary Coordinating Site
Room C1241B-1403-29th Street NW 
Foothills Medical Centre 
403-944-2863 ( office)

Email: esctrial@ucalgary.ca